Kura targets 2028 first top line KOMET-017 Phase III results as KOMZIFTI posts $5.8M in first full launch quarter
Kura Oncology, Inc. · PHARMACEUTICAL PREPARATIONS · Now $9.03
+19% in 7d after detection
Post-detection moves
1h
—
1d
+2.7%
3d
-3.0%
7d
+19%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS